See more : Kingwell Group Limited (1195.HK) Income Statement Analysis – Financial Results
Complete financial analysis of McKesson Corporation (MCK) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of McKesson Corporation, a leading company in the Medical – Distribution industry within the Healthcare sector.
You may be interested
- Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (300255.SZ) Income Statement Analysis – Financial Results
- City of London Group plc (CIN.L) Income Statement Analysis – Financial Results
- Lumiera Health Inc. (NHPHF) Income Statement Analysis – Financial Results
- GenMont Biotech Incorporation (3164.TW) Income Statement Analysis – Financial Results
- Brookfield Asset Management Inc. PFD SR 48 CL A (BAM-PFJ.TO) Income Statement Analysis – Financial Results
McKesson Corporation (MCK)
About McKesson Corporation
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The International segment offers distribution and services to wholesale, institutional, and retail customers in 13 European countries and Canada. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers. The RxTS segment serves biopharma and life sciences partners and patients to address medication challenges for patients throughout their journeys; connects pharmacies, providers, payers, and biopharma companies to deliver innovative access and adherence solutions; and provides third-party logistics and wholesale distribution support solutions. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 308.95B | 276.71B | 263.97B | 238.23B | 231.05B | 214.32B | 208.36B | 198.53B | 190.88B | 179.05B | 137.61B | 122.46B | 122.73B | 112.08B | 108.70B | 106.63B | 101.70B | 92.98B | 88.05B | 80.51B | 69.51B | 57.12B | 50.01B | 42.01B | 36.73B | 30.38B | 20.86B | 12.89B | 13.72B | 13.19B |
| Cost of Revenue | 296.37B | 264.35B | 250.84B | 226.08B | 219.03B | 202.57B | 197.17B | 187.26B | 179.47B | 167.63B | 129.30B | 115.47B | 116.17B | 106.11B | 103.03B | 101.25B | 96.69B | 88.65B | 84.19B | 77.05B | 66.26B | 54.02B | 47.21B | 39.58B | 34.21B | 27.52B | 19.25B | 11.78B | 12.50B | 12.03B |
| Gross Profit | 12.58B | 12.36B | 13.13B | 12.15B | 12.02B | 11.75B | 11.18B | 11.27B | 11.42B | 11.41B | 8.31B | 6.98B | 6.57B | 5.97B | 5.68B | 5.38B | 5.01B | 4.33B | 3.86B | 3.46B | 3.25B | 3.10B | 2.80B | 2.43B | 2.52B | 2.86B | 1.61B | 1.11B | 1.22B | 1.16B |
| Gross Profit Ratio | 4.07% | 4.47% | 4.97% | 5.10% | 5.20% | 5.48% | 5.37% | 5.68% | 5.98% | 6.37% | 6.04% | 5.70% | 5.35% | 5.33% | 5.22% | 5.04% | 4.93% | 4.66% | 4.39% | 4.30% | 4.67% | 5.43% | 5.59% | 5.79% | 6.87% | 9.43% | 7.71% | 8.61% | 8.88% | 8.82% |
| Research & Development | 179.00M | 89.00M | 70.00M | 74.00M | 96.00M | 71.00M | 125.00M | 341.00M | 392.00M | 392.00M | 456.00M | 480.00M | 440.00M | 407.00M | 376.00M | 364.00M | 347.00M | 284.00M | 223.00M | 182.00M | 172.70M | 149.40M | 135.10M | 147.50M | 112.60M | 114.70M | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 6.91B | 15.55B | 21.07B | 17.70B | 18.34B | 8.40B | 8.14B | 7.47B | 7.28B | 7.90B | 5.42B | 2.35B | 3.07B | 2.76B | 2.57B | 3.08B | 3.19B | 2.79B | 2.48B | 2.27B | 2.09B | 2.02B | 1.95B | 2.08B | 2.05B | 2.22B | 1.16B | 944.50M | 872.90M | 1.12B |
| Selling & Marketing | 1.10B | -7.78B | -10.54B | -8.85B | -9.17B | -8.40B | -8.14B | -7.47B | -7.28B | -7.90B | -5.42B | 1.85B | 764.00M | 767.00M | 746.00M | 743.00M | 744.00M | 673.00M | 611.00M | 550.10M | 513.10M | 499.00M | 427.10M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 8.20B | 7.78B | 10.54B | 8.85B | 9.17B | 8.40B | 8.14B | 7.80B | 7.67B | 8.29B | 5.87B | 4.20B | 149.00M | 3.94B | 3.31B | 3.82B | 3.19B | 2.79B | 2.48B | 2.27B | 2.09B | 2.02B | 1.95B | 2.08B | 2.05B | 2.22B | 1.16B | 944.50M | 872.90M | 1.12B |
| Other Expenses | 298.00M | 497.00M | 259.00M | 223.00M | 12.00M | 182.00M | 130.00M | 90.00M | 58.00M | 63.00M | 32.00M | 10.00M | 3.21B | 2.98B | -20.00M | 3.08B | -5.00M | -6.00M | 45.00M | 1.20B | 0.00 | 0.00 | 22.00M | 111.60M | 201.30M | 199.30M | 87.20M | 71.80M | 71.30M | 69.80M |
| Operating Expenses | 8.68B | 7.78B | 10.54B | 8.85B | 9.26B | 8.47B | 8.26B | 7.80B | 7.67B | 8.29B | 5.87B | 4.68B | 4.42B | 3.94B | 3.67B | 4.18B | 3.53B | 3.07B | 2.75B | 3.66B | 2.26B | 2.17B | 2.10B | 2.33B | 2.37B | 2.53B | 1.25B | 1.02B | 944.20M | 1.19B |
| Cost & Expenses | 305.04B | 272.13B | 261.37B | 234.93B | 228.29B | 211.04B | 205.44B | 195.06B | 187.14B | 175.93B | 135.17B | 120.15B | 120.59B | 110.05B | 106.69B | 105.44B | 100.23B | 91.71B | 86.94B | 80.71B | 68.52B | 56.19B | 49.31B | 41.91B | 36.58B | 30.05B | 20.50B | 12.79B | 13.44B | 13.22B |
| Interest Income | 118.00M | 107.00M | 10.00M | 12.00M | 49.00M | 39.00M | 48.00M | 29.00M | 18.00M | 20.00M | 23.00M | 22.00M | 19.00M | 18.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 252.00M | 248.00M | 178.00M | 217.00M | 249.00M | 264.00M | 283.00M | 308.00M | 353.00M | 374.00M | 303.00M | 240.00M | 251.00M | 222.00M | 187.00M | 144.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 635.00M | 857.00M | 1.00B | 1.22B | 922.00M | 949.00M | 951.00M | 910.00M | 885.00M | 1.02B | 704.00M | 591.00M | 551.00M | 496.00M | 474.00M | 441.00M | 371.00M | 295.00M | 266.00M | 250.90M | 232.10M | 203.70M | 207.50M | 246.10M | 201.30M | 199.30M | 87.20M | 71.80M | 71.30M | 69.80M |
| EBITDA | 4.67B | 5.74B | 3.11B | -3.60B | 2.32B | 4.06B | 3.86B | 4.39B | 4.56B | 4.14B | 3.06B | 2.74B | 2.72B | 2.33B | 2.53B | 1.65B | 1.85B | 1.56B | 1.39B | 29.00M | 1.21B | 929.90M | 905.00M | 450.30M | 332.10M | 531.50M | 449.40M | 164.60M | 345.40M | 50.10M |
| EBITDA Ratio | 1.51% | 2.06% | 1.37% | 1.85% | 1.12% | 1.97% | 1.80% | 2.25% | 2.46% | 2.34% | 2.30% | 2.39% | 2.20% | 2.26% | 2.28% | 1.54% | 1.80% | 1.66% | 1.46% | 1.48% | 1.68% | 1.90% | 1.79% | 1.01% | 0.25% | 1.75% | 2.15% | 1.28% | 2.52% | 0.26% |
| Operating Income | 3.91B | 4.38B | 2.85B | 3.52B | 1.66B | 886.00M | 762.00M | 7.11B | 3.55B | 2.97B | 2.37B | 2.32B | 2.15B | 1.82B | 2.01B | 1.20B | 1.48B | 1.26B | 1.11B | -190.50M | 983.40M | 929.90M | 693.60M | 96.40M | 158.20M | 332.20M | 362.20M | 92.80M | 274.10M | -30.10M |
| Operating Income Ratio | 1.27% | 1.58% | 1.08% | 1.48% | 0.72% | 0.41% | 0.37% | 3.58% | 1.86% | 1.66% | 1.72% | 1.89% | 1.75% | 1.62% | 1.85% | 1.12% | 1.45% | 1.36% | 1.27% | -0.24% | 1.41% | 1.63% | 1.39% | 0.23% | 0.43% | 1.09% | 1.74% | 0.72% | 2.00% | -0.23% |
| Total Other Income/Expenses | -120.00M | 249.00M | -110.00M | 6.00M | -1.35B | -276.00M | -523.00M | -231.00M | -295.00M | -311.00M | -343.00M | -396.00M | -230.00M | -186.00M | -144.00M | -132.00M | -21.00M | 33.00M | 44.00M | -54.50M | -72.00M | -74.50M | -87.50M | -196.30M | 148.70M | -130.20M | -109.40M | -61.70M | -44.40M | -23.40M |
| Income Before Tax | 3.79B | 4.63B | 1.93B | -5.03B | 1.14B | 610.00M | 239.00M | 6.89B | 3.25B | 2.66B | 2.10B | 1.92B | 1.92B | 1.64B | 1.86B | 1.06B | 1.46B | 1.30B | 1.16B | -239.80M | 911.40M | 855.40M | 601.20M | 9.60M | 306.90M | 202.00M | 253.50M | 36.40M | 224.10M | -81.70M |
| Income Before Tax Ratio | 1.23% | 1.67% | 0.73% | -2.11% | 0.50% | 0.28% | 0.11% | 3.47% | 1.70% | 1.48% | 1.52% | 1.57% | 1.56% | 1.46% | 1.71% | 1.00% | 1.43% | 1.39% | 1.32% | -0.30% | 1.31% | 1.50% | 1.20% | 0.02% | 0.84% | 0.66% | 1.22% | 0.28% | 1.63% | -0.62% |
| Income Tax Expense | 629.00M | 905.00M | 636.00M | -695.00M | 18.00M | 356.00M | -53.00M | 1.61B | 908.00M | 815.00M | 742.00M | 581.00M | 516.00M | 505.00M | 601.00M | 241.00M | 468.00M | 329.00M | 421.00M | -83.10M | 264.90M | 293.30M | 182.60M | 52.30M | 122.30M | 117.10M | 98.60M | 31.30M | 88.70M | 111.50M |
| Net Income | 3.00B | 3.56B | 1.11B | -4.34B | 900.00M | 34.00M | 67.00M | 5.07B | 2.26B | 1.48B | 1.26B | 1.34B | 1.40B | 1.20B | 1.26B | 823.00M | 990.00M | 913.00M | 751.00M | -156.70M | 646.50M | 555.40M | 418.60M | -48.30M | 723.70M | 84.90M | 154.90M | 133.90M | 135.40M | 404.50M |
| Net Income Ratio | 0.97% | 1.29% | 0.42% | -1.82% | 0.39% | 0.02% | 0.03% | 2.55% | 1.18% | 0.82% | 0.92% | 1.09% | 1.14% | 1.07% | 1.16% | 0.77% | 0.97% | 0.98% | 0.85% | -0.19% | 0.93% | 0.97% | 0.84% | -0.11% | 1.97% | 0.28% | 0.74% | 1.04% | 0.99% | 3.07% |
| EPS | 22.54 | 25.23 | 7.31 | -27.02 | 4.97 | 0.17 | 0.32 | 22.95 | 9.82 | 6.37 | 5.51 | 5.71 | 5.70 | 4.65 | 4.70 | 2.99 | 3.40 | 3.06 | 2.46 | -0.53 | 2.23 | 1.92 | 1.47 | -0.17 | 2.57 | 0.31 | 1.14 | 0.83 | 1.53 | 4.60 |
| EPS Diluted | 22.39 | 25.04 | 7.23 | -27.02 | 4.95 | 0.17 | 0.32 | 22.73 | 9.70 | 6.27 | 5.41 | 5.59 | 5.59 | 4.57 | 4.62 | 2.95 | 3.32 | 2.99 | 2.38 | -0.53 | 2.19 | 1.88 | 1.43 | -0.17 | 2.55 | 0.31 | 1.10 | 0.80 | 1.45 | 4.43 |
| Weighted Avg Shares Out | 133.20M | 141.10M | 152.30M | 160.60M | 181.00M | 196.30M | 208.00M | 221.00M | 230.00M | 232.00M | 229.00M | 235.00M | 246.00M | 258.00M | 269.00M | 275.00M | 291.00M | 298.00M | 306.00M | 294.00M | 290.00M | 289.30M | 285.20M | 283.10M | 281.30M | 275.20M | 282.10M | 83.65M | 88.50M | 87.93M |
| Weighted Avg Shares Out (Dil) | 134.10M | 142.20M | 154.10M | 160.60M | 182.00M | 197.30M | 209.00M | 223.00M | 233.00M | 235.00M | 233.00M | 239.00M | 251.00M | 263.00M | 273.00M | 279.00M | 298.00M | 305.00M | 316.00M | 294.00M | 299.00M | 298.80M | 298.10M | 283.10M | 284.20M | 275.20M | 282.10M | 84.39M | 93.38M | 91.31M |
Here's Why McKesson (MCK) is a Strong Value Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
3 Reasons Why You Should Hold McKesson (MCK) Stock for Now
McKesson's (MCK) robust Biologics business raises optimism about the stock.
McKesson (MCK) Declines More Than Market: Some Information for Investors
In the latest trading session, McKesson (MCK) closed at $575.23, marking a -1.98% move from the previous day.
Here's Why McKesson (MCK) is a Strong Momentum Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Investors Heavily Search McKesson Corporation (MCK): Here is What You Need to Know
Recently, Zacks.com users have been paying close attention to McKesson (MCK). This makes it worthwhile to examine what the stock has in store.
Why McKesson (MCK) is a Top Value Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Here is What to Know Beyond Why McKesson Corporation (MCK) is a Trending Stock
Zacks.com users have recently been watching McKesson (MCK) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
McKesson (MCK) Stock Slides as Market Rises: Facts to Know Before You Trade
In the latest trading session, McKesson (MCK) closed at $599.56, marking a -0.8% move from the previous day.
McKesson Corporation Announces First Quarter Fiscal 2025 Earnings Release Date
IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) will release its first quarter fiscal 2025 financial results after market close on Wednesday, August 7, 2024. The company will host a live webcast of the earnings conference call for investors at 4:30 PM...
Outcomes® Showcased at McKesson ideaShare 2024
NEW ORLEANS--(BUSINESS WIRE)--Outcomes, a leader in integrated pharmacy workflow and patient engagement solutions, announced that it will feature a new prescription counting solution, Pill Count, at McKesson ideaShare. By leveraging AI and machine learning, Pill Count™ makes counting pills easier...
Source: https://incomestatements.info
Category: Stock Reports